Stratus Medical, a medical device company, has recently announced the initiation of participant enrollment for its Nimbus RF device clinical trial. The trial is designed to evaluate the safety and efficacy of the device for the treatment of chronic lower back pain.

The Nimbus RF device is a minimally invasive, non-surgical treatment option for chronic lower back pain. It uses radiofrequency energy to target and reduce pain in the affected area. The device is designed to provide long-term relief from chronic lower back pain without the need for surgery or other invasive treatments.

The clinical trial will involve a total of 30 participants, who will be randomly assigned to either receive the Nimbus RF device or a sham procedure. Participants will be followed for 12 months after their initial treatment to assess the safety and efficacy of the device. The primary outcome measure will be the change in pain intensity from baseline to 12 months post-treatment.

The trial is being conducted at three sites in the United States and is expected to be completed by the end of 2021. Stratus Medical is hopeful that the results of the trial will demonstrate that the Nimbus RF device is a safe and effective treatment option for chronic lower back pain. If successful, the device could provide an alternative to more invasive treatments such as surgery, which can be costly and have a lengthy recovery time.

Stratus Medical is committed to providing innovative solutions to improve patient outcomes and quality of life. The company is dedicated to developing safe and effective treatments that can help patients suffering from chronic lower back pain. The initiation of participant enrollment for the Nimbus RF device clinical trial marks an important step in this journey.

Source: Plato Data Intelligence: PlatoAiStream